Article metrics
PDFFRIDAY, 15 JUNE 2018
Present and future treatments for SLE, Sjögren’s and APS
OP0253 A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritis
